33333995|t|Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.
33333995|a|The twenty-first century has witnessed some of the deadliest viral pandemics with far-reaching consequences. These include the Human Immunodeficiency Virus (HIV) (1981), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) (2002), Influenza A virus subtype H1N1 (A/H1N1) (2009), Middle East Respiratory Syndrome Coronavirus (MERS-CoV) (2012) and Ebola virus (2013) and the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) (2019-present). Age- and gender-based characterizations suggest that SARS-CoV-2 resembles SARS-CoV and MERS-CoV with regard tohigher fatality rates in males, and in the older population with comorbidities. The invasion-mechanism of SARS-CoV-2 and SARS-CoV, involves binding of its spike protein with angiotensin-converting enzyme 2 (ACE2) receptors; MERS-CoV utilizes dipeptidyl peptidase 4 (DPP4), whereas H1N1 influenza is equipped with hemagglutinin protein. The viral infections-mediated immunomodulation, and progressive inflammatory state may affect the functions of several other organs. Although no effective commercial vaccine is available for any of the viruses, those against SARS-CoV-2 are being developed at an unprecedented speed. Until now, only Pfizer/BioNTech's vaccine has received temporary authorization from the UK Medicines and Healthcare products Regulatory Agency. Given the frequent emergence of viral pandemics in the 21st century, proper understanding of their characteristics and modes of action are essential to address the immediate and long-term health consequences.
33333995	0	15	Viral Pandemics	Disease	MESH:D014777
33333995	153	168	viral pandemics	Disease	MESH:D014777
33333995	219	247	Human Immunodeficiency Virus	Species	12721
33333995	249	252	HIV	Species	12721
33333995	262	307	Severe Acute Respiratory Syndrome Coronavirus	Disease	MESH:D000086382
33333995	309	317	SARS-CoV	Disease	MESH:D000086382
33333995	327	344	Influenza A virus	Species	11320
33333995	353	357	H1N1	Species	114727
33333995	359	360	A	Species	
33333995	361	365	H1N1	Species	114727
33333995	375	419	Middle East Respiratory Syndrome Coronavirus	Disease	MESH:D018352
33333995	421	429	MERS-CoV	Disease	MESH:D018352
33333995	442	453	Ebola virus	Species	186536
33333995	469	516	Severe Acute Respiratory Syndrome Coronavirus-2	Disease	MESH:D000086382
33333995	518	528	SARS-CoV-2	Disease	MESH:D000086382
33333995	599	609	SARS-CoV-2	Disease	MESH:D000086382
33333995	620	628	SARS-CoV	Disease	MESH:D000086382
33333995	633	641	MERS-CoV	Disease	MESH:D018352
33333995	762	772	SARS-CoV-2	Disease	MESH:D000086382
33333995	777	785	SARS-CoV	Disease	MESH:D000086382
33333995	830	861	angiotensin-converting enzyme 2	Gene	59272
33333995	863	867	ACE2	Gene	59272
33333995	880	888	MERS-CoV	Disease	MESH:D018352
33333995	898	920	dipeptidyl peptidase 4	Gene	1803
33333995	922	926	DPP4	Gene	1803
33333995	937	951	H1N1 influenza	Species	
33333995	969	982	hemagglutinin	Gene	
33333995	996	1012	viral infections	Disease	MESH:D014777
33333995	1056	1068	inflammatory	Disease	MESH:D007249
33333995	1217	1227	SARS-CoV-2	Disease	MESH:D000086382
33333995	1451	1466	viral pandemics	Disease	MESH:D014777
33333995	Association	MESH:D018352	1803
33333995	Association	MESH:D000086382	59272

